2025-04-08 18:26:23
Latest Post
Godrej Properties delivers its highest ever quarterly and full year bookings
Poonawalla Fincorp Launches Shopkeeper Loan Business
Revolt Motors Expands to 200 Dealerships, Targets 400 by FY26
Sobha Ltd - Real Estate Operational Update - Q4 FY 2024-25
Lemon Tree Hotels signs a new property in DarjeelingStock Report
Dr. Lal Path Labs Ltd Q4FY22 consolidated net profit up QoQ at Rs. 61.3 crores
Posted On : 2022-05-17 15:56:58( TIMEZONE : IST )
Dr. Lal Path Labs Ltd. has reported Consolidated financial results for the period ended March 31, 2022.
Financial Results (Q4 FY2022) - QoQ Comparison
The company has reported total income of Rs. 497.5 crores during the period ended March 31, 2022 as compared to Rs. 509 crores during the period ended December 31, 2021.
The company has posted net profit / (loss) of Rs. 61.3 crores for the period ended March 31, 2022 as against net profit / (loss) of Rs. 57.3 crores for the period ended December 31, 2021.
The company has reported EPS of Rs. 7.38 for the period ended March 31, 2022 as compared to Rs. 6.90 for the period ended December 31, 2021.
| Financials | Q4 FY2022 | Q3 FY2022 | % Change |
| Total Income | ₹ 497.5 crs | ₹509 crs |  -2.26% |
| Net Profit | ₹61.3 crs | ₹57.3 crs |  6.98% |
| EPS | ₹7.38 | ₹6.90 | 6.96% |
Financial Results (Q4 FY2022) - YoY Comparison
The company has reported total income of Rs. 497.5 crores during the period ended March 31, 2022 as compared to Rs.444.5 crores during the period ended March 31, 2021.
The company has posted net profit / (loss) of Rs.61.3 crores for the period ended March 31, 2022 as against net profit / (loss) of Rs.83.4 crores for the period ended March 31, 2021.
The company has reported EPS of Rs.7.38 for the period ended March 31, 2022 as compared to Rs.10.07 for the period ended March 31, 2021.
| Financials | Q4 FY2022 | Q4 FY2021 | % Change |
| Total Income | ₹ 497.5 crs | ₹444.5 crs | 11.92% |
| Net Profit | ₹61.3 crs | ₹83.4 crs | -26.50% |
| EPS | ₹7.38 | ₹10.07 | -26.71% |
Financial Results (Year Ended FY2022) - YoY Comparison
The company has reported total income of Rs.2139.9 crores during the Financial Year ended March 31, 2022 as compared to Rs.1632.6 crores during the Financial Year ended March 31, 2021.
The company has posted net profit / (loss) of Rs.344.8 crores for the Financial Year ended March 31, 2022 as against net profit / (loss) of Rs.291.6 crores for the Financial Year ended March 31, 2021.
The company has reported EPS of Rs.41.57 for the Financial Year ended March 31, 2022 as compared to Rs.35.25 for the Financial Year ended March 31, 2021.
| Financials | Year Ended FY2022 | Year Ended FY2021 | % Change |
| Total Income | ₹2139.9 crs | ₹1632.6 crs | 31.07% |
| Net Profit | ₹344.8 crs | ₹291.6 crs | 18.24% |
| EPS | ₹41.57 | ₹35.25 | 17.93% |
Shares of Dr. Lal Path Labs Ltd. was last trading in BSE at Rs. 2206.55 as compared to the previous close of Rs. 2285.25. The total number of shares traded during the day was 38227 in over 5448 trades.
The stock hit an intraday high of Rs. 2285.25 and intraday low of 2151.05. The net turnover during the day was Rs. 84096720.00.
